Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility

scientific article published on 01 October 2003

Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0009-9120(03)00096-1
P698PubMed publication ID14563446

P50authorWojciech KisielewskiQ59704720
P2093author name stringMaurice M A L Pelsers
Jan F C Glatz
Andrzej Namiot
Wim T Hermens
Zbigniew Namiot
Marcin Januszkiewicz
P2860cites workDiscrimination Between Myocardial and Skeletal Muscle Injury by Assessment of the Plasma Ratio of Myoglobin Over Fatty Acid–Binding ProteinQ34297538
Intestinal fatty acid binding protein is available for diagnosis of intestinal ischaemia: immunochemical analysis of two patients with ischaemic intestinal diseasesQ34408362
Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transportQ34464839
The recovery of function and microcirculation in small intestinal loops following ischaemiaQ34475523
Progress in myocardial damage detection: new biochemical markers for cliniciansQ41367903
Cellular fatty acid-binding proteins: their function and physiological significanceQ41397842
Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot studyQ44865503
Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass: a preliminary analysisQ44883997
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance ratesQ47246076
Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assaysQ47795781
Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass.Q51672701
Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates.Q52026486
Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NECQ70649317
Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humansQ70912541
Small bowel allograft rejection detected by serum intestinal fatty acid-binding protein is reversibleQ71085134
Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemiaQ73151870
One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding proteinQ73354803
Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejectionQ73930452
Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding proteinQ74146978
Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemiaQ74339590
Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: an early marker for acute myocardial infarctionQ77925906
P433issue7
P304page(s)529-535
P577publication date2003-10-01
P1433published inClinical BiochemistryQ5133749
P1476titleIntestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility
P478volume36

Reverse relations

cites work (P2860)
Q47163293A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence
Q37294167Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis
Q35640599Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals
Q91878345Association between endotoxemia and enterocyte injury and clinical course in patients with gram-positive septic shock: A posthoc analysis of a prospective observational study
Q54174857Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects.
Q35800550Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels
Q37317771Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection
Q39325747Biomarkers and non-invasive tests for gastrointestinal mucositis
Q36859128Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.
Q30275811Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil
Q41902202Bowel Ischemia in ICU Patients: Diagnostic Value of I-FABP Depends on the Interval to the Triggering Event
Q93034302Brief Report: Gut Structural Damage: an Ongoing Process in Chronically Untreated HIV Infection
Q90693849Brief Report: Zinc Supplementation and Inflammation in Treated HIV
Q50992669Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure.
Q35054010Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population
Q33281085Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium
Q37378495Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6.
Q63515300Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes
Q30268540Determinant Variables, Enteric Pathogen Burden, Gut Function, and Immune-Related Inflammatory Biomarkers Associated with Childhood Malnutrition: A Prospective Case-Control Study in Northeastern Brazil
Q52053440Development of a porcine small intestinal cDNA micro-array: characterization and functional analysis of the response to enterotoxigenic E. coli.
Q37358567Diagnosis and management of splanchnic ischemia
Q51058766Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study.
Q89928163Diagnostic accuracy of urinary intestinal fatty acid binding protein in detecting colorectal anastomotic leakage
Q92002919Effect of Huangqin Tang on Colonic Gene Expression in Rats with Ulcerative Colitis
Q94551906Effect of Huangqin Tang on Urine Metabolic Profile in Rats with Ulcerative Colitis Based on UPLC-Q-Exactive Orbitrap MS
Q35926782Effects of silver nanoparticles and ions on a co-culture model for the gastrointestinal epithelium
Q37656786Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure
Q40736165Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury
Q35071134Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine
Q35814231Evidence for a Cystic Fibrosis Enteropathy
Q42594413Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy
Q92124140Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas
Q44582581Expression pattern of L-FABP gene in different tissues and its regulation of fat metabolism-related genes in duck
Q27322647Extensive expression differences along porcine small intestine evidenced by transcriptome sequencing
Q35042217Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
Q33223853Gene expression profiling of jejunal Peyer's patches in juvenile and adult pigs
Q37440936Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression
Q26773267Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity
Q91916978Gut permeability, inflammation, and bone density across the menopause transition
Q35269130Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection
Q59805967I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV
Q47828822I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients.
Q34303381Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.
Q36199763Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease
Q47251751Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction
Q89775610Increased monocyte and T-cell activation in treated HIV+ ugandan children: associations with gut alteration and HIV factors
Q38267212Insights from human congenital disorders of intestinal lipid metabolism
Q35126230Interaction of enterocyte FABPs with phospholipid membranes: clues for specific physiological roles
Q37715738Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study.
Q42262442Intestinal barrier integrity and function in infants with cholestasis
Q37471655Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease
Q34476223Intestinal fatty-acid binding protein and metronidazole response in premature infants
Q47243096Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials
Q91936388Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients?
Q90720520Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
Q34575989Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy
Q51471819L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women.
Q57800469Leaky Gut Biomarkers in Depression and Suicidal Behavior
Q35185218Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice.
Q57111128Lower pretreatment gut integrity is independently associated with fat gain on antiretroviral therapy
Q39278519Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy
Q36215001Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication
Q36558287Microbial translocation in the pathogenesis of HIV infection and AIDS.
Q40478716Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression.
Q37821275Non-invasive assessment of barrier integrity and function of the human gut.
Q34510967Novel potential interacting partners of fibronectin in spontaneous animal model of interstitial cystitis
Q34764002Plasma levels of soluble CD14 independently predict mortality in HIV infection
Q36929093Prediction of Gut Wall Integrity Loss in Viral Gastroenteritis by Non-Invasive Marker
Q33812820Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals.
Q36282619Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury
Q37279857Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study.
Q28268205Recent insights into the biological functions of liver fatty acid binding protein 1
Q92269205Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations
Q34345547Role of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli.
Q64245096Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART
Q64240440Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome
Q34534552Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia
Q90187123Strongyloides stercoralis Infection in Solid Organ Transplant Patients is Associated with Eosinophil Activation and Intestinal Inflammation: A Cross-sectional Study
Q91594611Superior intestinal integrity and limited microbial translocation are associated with lower immune activation in SIVmac239-infected northern pig-tailed macaques (Macaca leonina)
Q33934080Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial
Q42128377Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis.
Q35965167The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals
Q26992027The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon
Q90141454The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases
Q34789326The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation
Q28833221The biogenesis of chylomicrons
Q49651262The effects of dietary sulfur amino acids on growth performance, intestinal morphology, enzyme activity, and nutrient transporters in weaning piglets
Q28277155The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins
Q40835189The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity.
Q34146203Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia
Q90451647Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease
Q36773550Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease
Q33754526Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction
Q43929358Value of the serum I-FABP level for diagnosing acute mesenteric ischemia

Search more.